HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

TVRD

Tvardi Therapeutics Inc

Last Close
Apr 21 • 04:00PM ET
17.47
Dollar change
+0.43
Percentage change
2.53 		%
Healthcare • Biotechnology • USA • NASD
Peers: GILD VRTX BPMC ARWR SRPT AVXL AMRN NKTR LGND OPK
 | Held by: VTI VXF
Scroll to Statements
Index- P/E- EPS (ttm)-46.64 Insider Own- Shs Outstand1.52M Perf Week18.84%
Market Cap54.48M Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month13.07%
Income-70.87M PEG- EPS next Q-0.38 Inst Own23.13% Short Float- Perf Quarter25.23%
Sales7.14M P/S7.63 EPS this Y- Inst Trans- Short Ratio2.38 Perf Half Y83.12%
Book/sh-3.01 P/B- EPS next Y- ROA-83.53% Short Interest0.02M Perf Year-33.70%
Cash/sh12.15 P/C1.44 EPS next 5Y- ROE-270.01% 52W Range8.13 - 31.32 Perf YTD-4.85%
Dividend Est.- P/FCF- EPS past 5Y12.29% ROI-177.81% 52W High-44.22% Beta0.23
Dividend TTM- Quick Ratio10.81 Sales past 5Y92.45% Gross Margin100.66% 52W Low115.01% ATR (14)1.88
Dividend Ex-Date- Current Ratio11.03 EPS Y/Y TTM40.80% Oper. Margin-781.57% RSI (14)60.73 Volatility27.71% 10.79%
Employees10 Debt/Eq- Sales Y/Y TTM-65.96% Profit Margin-992.95% Recom2.60 Target Price36.00
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q76.42% Payout- Rel Volume1.11 Prev Close17.04
Sales Surprise26.80% EPS Surprise-40.70% Sales Q/Q-51.56% Earnings- Avg Volume9.32K Price17.47
SMA2011.26% SMA5013.85% SMA20037.01% Trades Volume10,303 Change2.53%
Date Action Analyst Rating Change Price Target Change
Jun-13-24Downgrade Stifel Buy → Hold $6 → $1
Jun-13-24Downgrade Needham Buy → Hold
Jun-13-24Downgrade H.C. Wainwright Buy → Neutral
Jun-13-24Downgrade Canaccord Genuity Buy → Hold $10 → $1
Mar-08-23Downgrade BofA Securities Neutral → Underperform $13 → $6
Mar-08-22Upgrade JP Morgan Neutral → Overweight $17 → $20
Nov-01-21Resumed Canaccord Genuity Buy $33
Aug-03-21Initiated JP Morgan Neutral $16
Apr-21-20Reiterated H.C. Wainwright Buy $30 → $33
Aug-12-19Reiterated H.C. Wainwright Buy $31 → $30
Show Previous Ratings
Apr-14-25 11:50AM
Cara Therapeutics Announces 1-for-3 Reverse Stock Split in Connection with the Proposed Merger with Tvardi Therapeutics
(GlobeNewswire) +13.26%
Dec-27-24 07:00AM
Cara Therapeutics Announces Effective Date of 1-for-12 Reverse Stock Split
(GlobeNewswire) -15.98%
Dec-18-24 07:00AM
Cara Therapeutics and Tvardi Therapeutics Announce Entry into Merger Agreement
(GlobeNewswire)
06:45AM
Tessera gets sickle cell funding; Corvus shares slide on eczema data
(BioPharma Dive)
Nov-14-24 07:31PM
Cara: Q3 Earnings Snapshot
(Associated Press Finance) -5.04%
01:55PM Loading…
Aug-15-24 01:55PM
Cara: Q2 Earnings Snapshot
(Associated Press Finance)
Jul-11-24 07:00AM
Cara Therapeutics Announces Exploration of Strategic Alternatives
(GlobeNewswire) +27.97%
Jun-13-24 09:51AM
Chipotle, McDonald's initiated: Wall Street's top analyst calls
(The Fly) -34.72%
Jun-12-24 04:01PM
Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica
(GlobeNewswire)
May-13-24 08:55PM
CARA Stock Earnings: Cara Therapeutics Misses EPS, Beats Revenue for Q1 2024
(InvestorPlace)
05:10PM
Cara Therapeutics (CARA) Reports Q1 Loss, Misses Revenue Estimates
(Zacks)
04:07PM
Cara: Q1 Earnings Snapshot
(Associated Press Finance)
04:01PM
Cara Therapeutics Reports First Quarter 2024 Financial Results
(GlobeNewswire)
May-06-24 07:00AM
Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024
(GlobeNewswire)
Apr-02-24 07:00AM
Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
(GlobeNewswire)
07:00AM Loading…
Mar-07-24 07:00AM
Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024
(GlobeNewswire) +6.05%
06:40AM
7 F-Rated Stocks to Sell in March 2024
(InvestorPlace)
Mar-05-24 09:07AM
Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2023 Earnings Call Transcript
(Insider Monkey) -8.98%
07:51AM
Q4 2023 Cara Therapeutics Inc Earnings Call
(Thomson Reuters StreetEvents)
Mar-04-24 08:51PM
CARA Stock Earnings: Cara Therapeutics Misses EPS, Misses Revenue for Q4 2023
(InvestorPlace) +5.24%
05:10PM
Cara Therapeutics (CARA) Reports Q4 Loss, Tops Revenue Estimates
(Zacks)
04:21PM
Cara: Q4 Earnings Snapshot
(Associated Press Finance)
04:01PM
Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
(GlobeNewswire)
Feb-12-24 04:01PM
Cara Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
(GlobeNewswire) -8.54%
Jan-22-24 10:19AM
Cara Layoffs 2024: What to Know About the Latest CARA Job Cuts
(InvestorPlace)
07:00AM
Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica Program and Extends Cash Runway into 2026
(GlobeNewswire)
Dec-18-23 07:00AM
Cara Therapeutics Announces Outcome from Dose-Finding Part A of KIND 1 Study Evaluating Oral Difelikefalin for Moderate-to-Severe Pruritus in Patients with Atopic Dermatitis
(GlobeNewswire) -48.85%
Nov-14-23 11:04AM
Cara Therapeutics, Inc. (NASDAQ:CARA) Q3 2023 Earnings Call Transcript
(Insider Monkey) -7.20%
08:48AM
Q3 2023 Cara Therapeutics Inc Earnings Call
(Thomson Reuters StreetEvents)
Nov-13-23 06:00PM
Cara (CARA) Reports Q3 Earnings: What Key Metrics Have to Say
(Zacks) +12.38%
04:15PM Loading…
04:15PM
Cara: Q3 Earnings Snapshot
(Associated Press Finance)
04:01PM
Cara Therapeutics Reports Third Quarter 2023 Financial Results
(GlobeNewswire)
Nov-09-23 11:38AM
These Biotech Stocks Could Double Your Money, According To Analysts
(Benzinga) -6.72%
Nov-06-23 10:00AM
Earnings Preview: Cara Therapeutics (CARA) Q3 Earnings Expected to Decline
(Zacks)
Nov-02-23 07:00AM
Cara Therapeutics Announces up to $40.0 Million Non-Dilutive Financing Agreement with HealthCare Royalty
(GlobeNewswire)
Oct-23-23 07:00AM
Cara Therapeutics to Announce Third Quarter 2023 Financial Results on November 13, 2023
(GlobeNewswire)
Sep-25-23 07:00AM
Cara Therapeutics Announces Approval of KORSUVA® IV Injection Syringe in Japan for the Treatment of Pruritus in Hemodialysis Patients
(GlobeNewswire)
Sep-05-23 07:00AM
Cara Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference
(GlobeNewswire) -10.00%
Aug-10-23 02:53AM
Cara Therapeutics, Inc. (NASDAQ:CARA) Q2 2023 Earnings Call Transcript
(Insider Monkey)
Aug-08-23 05:54AM
Q2 2023 Cara Therapeutics Inc Earnings Call
(Thomson Reuters StreetEvents)
Aug-07-23 05:15PM
Cara Therapeutics (CARA) Reports Q2 Loss, Tops Revenue Estimates
(Zacks) -5.75%
04:09PM
Cara: Q2 Earnings Snapshot
(Associated Press Finance)
04:01PM
Cara Therapeutics Reports Second Quarter 2023 Financial Results
(GlobeNewswire)
Aug-03-23 07:00AM
Cara Therapeutics Appoints Helen M. Boudreau to Board of Directors
(GlobeNewswire)
Aug-02-23 07:00AM
Cara Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference
(GlobeNewswire)
Jul-24-23 07:00AM
Cara Therapeutics to Announce Second Quarter 2023 Financial Results on August 7, 2023
(GlobeNewswire)
Jun-14-23 01:37PM
The past five years for Cara Therapeutics (NASDAQ:CARA) investors has not been profitable
(Simply Wall St.)
Jun-13-23 06:30AM
3 Small-Cap Stocks to Sell in June Before They Crash and Burn
(InvestorPlace)
Jun-02-23 06:46PM
Palo Alto Networks Set to S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
(PR Newswire)
Jun-01-23 07:00AM
Cara Therapeutics to Present at the Jefferies Healthcare Conference
(GlobeNewswire)
May-30-23 06:34PM
7 Stocks With 1,000% Upside Potential
(InvestorPlace) -7.56%
May-25-23 06:40AM
Cara Therapeutics, Inc.'s (NASDAQ:CARA) P/S Is On The Mark
(Simply Wall St.) -6.55%
May-18-23 04:53PM
Hero or Zero? 7 Speculative Small-Cap Stocks to Make You Rich or Broke.
(InvestorPlace) -8.22%
02:00AM
Kapruvia® (difelikefalin) recommended by England's NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus
(PR Newswire)
May-16-23 11:02AM
Q1 2023 Cara Therapeutics Inc Earnings Call
(Thomson Reuters StreetEvents) +7.23%
May-15-23 05:15PM
Cara Therapeutics (CARA) Reports Q1 Loss, Tops Revenue Estimates
(Zacks)
04:07PM
Cara: Q1 Earnings Snapshot
(AP Finance)
04:01PM
Cara Therapeutics Reports First Quarter 2023 Financial Results
(GlobeNewswire)
May-04-23 09:38AM
Cara Therapeutics, Inc. (NASDAQ:CARA) is a favorite amongst institutional investors who own 65%
(Simply Wall St.)
May-01-23 07:00AM
Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023
(GlobeNewswire)
Apr-26-23 08:00PM
CARA: What does Argus have to say about CARA?
(Argus Research)
Apr-10-23 07:00AM
Cara Therapeutics Announces Presentation at the 22nd Annual Needham Virtual Healthcare Conference
(GlobeNewswire)
Apr-07-23 08:41AM
We're Not Very Worried About Cara Therapeutics' (NASDAQ:CARA) Cash Burn Rate
(Simply Wall St.)
Mar-14-23 07:00AM
Cara Therapeutics Releases Inaugural Environmental, Social, and Governance Report
(GlobeNewswire)
Mar-11-23 07:19AM
Things Look Grim For Cara Therapeutics, Inc. (NASDAQ:CARA) After Today's Downgrade
(Simply Wall St.)
Mar-08-23 06:59AM
Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2022 Earnings Call Transcript
(Insider Monkey)
Mar-07-23 10:46AM
Metas stock up on report of more layoffs, and WeightWatchers telehealth deal gives it access to promising obesity drug market
(MarketWatch) -33.23%
10:02AM
Q4 2022 Cara Therapeutics Inc Earnings Call
(Thomson Reuters StreetEvents)
09:43AM
Cara Therapeutics stock sinks on larger-than-expected Q4 earnings miss
(Yahoo Finance Video)
08:05AM
Meta shares rise after new wave of layoffs, WeightWatchers stock makes gains after results and acquisition; Grindrs stock falls after profit drop
(MarketWatch)
Mar-06-23 07:39PM
These 2 Stocks Are Plunging After Hours Monday
(Motley Fool)
05:15PM
Cara Therapeutics (CARA) Reports Q4 Loss, Misses Revenue Estimates
(Zacks)
04:01PM
Cara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results
(GlobeNewswire)
Feb-27-23 10:00AM
Will Cara Therapeutics (CARA) Report Negative Earnings Next Week? What You Should Know
(Zacks)
Feb-21-23 07:00AM
Cara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023
(GlobeNewswire)
Feb-15-23 05:11AM
Cara Therapeutics, Inc. (NASDAQ:CARA) Analysts Just Cut Their EPS Forecasts Substantially
(Simply Wall St.)
Feb-08-23 05:00PM
Cara Therapeutics Announces Results from the KOMFORT Phase 2 Trial of Oral Difelikefalin for the Treatment of Pruritus in Notalgia Paresthetica Published in the New England Journal of Medicine
(GlobeNewswire)
Jan-17-23 07:00AM
Cara Therapeutics to Host Capital Markets Day on Thursday, February 16, 2023
(GlobeNewswire)
Jan-03-23 07:00AM
Cara Therapeutics Announces Presentation at the 41st Annual J.P. Morgan Healthcare Conference
(GlobeNewswire)
Dec-29-22 05:53AM
Cara Therapeutics (NASDAQ:CARA shareholders incur further losses as stock declines 8.8% this week, taking three-year losses to 35%
(Simply Wall St.) +8.61%
Nov-29-22 07:30AM
KemPharm Announces Appointment of Christopher Posner as New Independent Director
(GlobeNewswire)
Nov-09-22 06:08AM
Cara Therapeutics Third Quarter 2022 Earnings: Beats Expectations
(Simply Wall St.)
Nov-07-22 05:35PM
Cara Therapeutics (CARA) Reports Q3 Loss, Tops Revenue Estimates
(Zacks)
04:01PM
Cara Therapeutics Reports Third Quarter 2022 Financial Results
(GlobeNewswire)
Nov-04-22 08:46AM
Why Cara Therapeutics (CARA) Might Surprise This Earnings Season
(Zacks)
Nov-03-22 07:00AM
Cara Therapeutics Announces Appointment of Lisa von Moltke, M.D., to its Board of Directors
(GlobeNewswire)
Nov-02-22 10:01AM
Analysts Estimate Affimed N.V. (AFMD) to Report a Decline in Earnings: What to Look Out for
(Zacks) -5.80%
07:00AM
Cara Therapeutics to Present at Upcoming Investor Conferences
(GlobeNewswire)
Oct-31-22 10:00AM
Cara Therapeutics (CARA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
(Zacks)
Oct-30-22 08:51AM
Cara Therapeutics, Inc. (NASDAQ:CARA) is a favorite amongst institutional investors who own 67%
(Simply Wall St.)
Oct-24-22 07:00AM
Cara Therapeutics to Announce Third Quarter 2022 Financial Results on November 7, 2022
(GlobeNewswire)
Oct-18-22 09:55AM
Wall Street Analysts See a 133% Upside in Cara (CARA): Can the Stock Really Move This High?
(Zacks)
Oct-10-22 04:05PM
SWK Holdings' Subsidiary, Enteris BioPharma, Receives $5 Million Milestone Payment from Cara Therapeutics
(PR Newswire)
Sep-28-22 07:00AM
Cara Therapeutics Announces Difelikefalin (KORSUVA®) Injection New Drug Application Has Been Submitted in Japan
(GlobeNewswire)
Sep-20-22 09:47AM
Here's Why We're Not Too Worried About Cara Therapeutics' (NASDAQ:CARA) Cash Burn Situation
(Simply Wall St.)
Sep-12-22 07:00AM
Cara Therapeutics Appoints Ryan Maynard as Chief Financial Officer
(GlobeNewswire)
Sep-08-22 02:27PM
Cara Therapeutics Presents Results of Oral Difelikefalin In Painful Itching Disorder
(Benzinga)
08:15AM
Cara Therapeutics Presents Late-Breaking Results of the KOMFORT Phase 2 Trial of Oral Difelikefalin for Pruritus in Notalgia Paresthetica at the 31st EADV Congress
(GlobeNewswire)
Sep-06-22 07:00AM
Cara Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
(GlobeNewswire)
Aug-24-22 07:00AM
Cara Therapeutics to Host Virtual Notalgia Paresthetica Event on September 20, 2022
(GlobeNewswire)
Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. The company was founded in 2017 and is headquartered in Sugar Land, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Posner ChristopherPRESIDENT AND CEOFeb 28 '25Sale4.755832,76913,109Mar 04 04:59 PM
Terrillion ScottSEC'Y; CHIEF COMPLIANCE & G.C.Feb 28 '25Sale4.761637767,190Mar 04 04:58 PM
Posner ChristopherPRESIDENT AND CEOFeb 04 '25Sale4.723721,75613,692Feb 06 07:15 PM
Posner ChristopherPRESIDENT AND CEONov 04 '24Sale0.293,6681,064168,768Nov 06 04:51 PM
Posner ChristopherPRESIDENT AND CEOAug 01 '24Sale0.354,1491,452172,436Aug 02 04:05 PM
Posner ChristopherPRESIDENT AND CEOMay 02 '24Sale0.753,9362,952176,585May 06 04:15 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • theme settings • contact • help • privacy • do not sell my data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.